Lymphadenectomy at the time of nephroureterectomy for upper tract urothelial cancer

European Urology

Volumn 60, Issue 4, 2011, Pages 776-783

  Roscigno, Marco ^a   Brausi, Maurizio ^b,c   Heidenreich, Axel ^d   Lotan, Yair ^e   Margulis, Vitaly ^e   Shariat, Shahrokh F ^f   Van Poppel, Hendrik ^g   Zigeuner, Richard ^h  

^a OSPEDALI RIUNITI   (Italy)

^b Department of Urology ^*  (Italy)

^c Nuovo Ospedale S Agostino   (Italy)

^d RWTH AACHEN UNIVERSITY   (Germany)

^e UNIVERSITY OF TEXAS SOUTHWESTERN MEDICAL CENTER   (United States)

^f WEILL CORNELL MEDICAL COLLEGE   (United States)

^g UNIVERSITY HOSPITALS LEUVEN   (Belgium)

^h MEDICAL UNIVERSITY OF GRAZ   (Austria)

Author keywords

Lymphadenectomy; Lymphatic metastases; Nephroureterectomy; Survival; Upper tract urothelial neoplasms

Indexed keywords

BLADDER CANCER; CANCER ADJUVANT THERAPY; CANCER CHEMOTHERAPY; CANCER INVASION; CANCER STAGING; CANCER SURVIVAL; EXCISION; HUMAN; LAPAROSCOPIC SURGERY; LYMPH NODE DISSECTION; LYMPH NODE METASTASIS; LYMPHADENECTOMY; MEDLINE; NEPHROURETERECTOMY; PREDICTION; PRIORITY JOURNAL; PROGNOSIS; RADICAL NEPHROURETERECTOMY; REVIEW; TRANSITIONAL CELL CARCINOMA; TREATMENT OUTCOME; UPPER TRACT UROTHELIAL CARCINOMA;

CARCINOMA; CHEMOTHERAPY, ADJUVANT; HUMANS; LYMPH NODE EXCISION; NEOPLASM STAGING; NEPHRECTOMY; PATIENT SELECTION; TREATMENT OUTCOME; URETER; URINARY BLADDER NEOPLASMS;

EID: 80052270135     PISSN: 03022838     EISSN: 18737560     Source Type: Journal    
DOI: 10.1016/j.eururo.2011.07.009     Document Type: Review

References (47)

1. A. Jemal, R. Siegel, E. Ward, T. Murray, J. Xu, and M.J. Thun Cancer statistics, 2007 CA Cancer J Clin 57 2007 43 66 (Pubitemid 46148091)
2. R. Zigeuner, and K. Pummer Urothelial carcinoma of the upper urinary tract: surgical approach and prognostic factors Eur Urol 53 2008 720 731
3. M. Ozsahin, A. Zouhair, and S. Villa Prognostic factors in urothelial renal pelvis and ureter tumours: a multicentre Rare Cancer Network study Eur J Cancer 35 1999 738 743 (Pubitemid 29258143)
4. A. Karl, P.R. Carroll, and J.E. Gschwend The impact of lymphadenectomy and lymph node metastasis on the outcomes of radical cystectomy for bladder cancer Eur Urol 55 2009 826 835
5. T.M. Koppie, A.J. Vickers, and K. Vora Standardization of pelvic lymphadenectomy performed at radical cystectomy: can we establish a minimum number of lymph nodes that should be removed? Cancer 107 2006 2368 2374 (Pubitemid 44748519)
6. J. Leissner, R. Hohenfellner, and J.W. Thuroff Lymphadenectomy in patients with transitional cell carcinoma of the urinary bladder: significance for staging and prognosis BJU Int 85 2000 817 823 (Pubitemid 30242784)
7. H.W. Herr, B.H. Bochner, and G. Dalbagni Impact of the number of lymph nodes retrieved on outcome in patients with muscle invasive bladder cancer J Urol 167 2002 1295 1298 (Pubitemid 34132073)
8. B.R. Konety, S.A. Joslyn, and M.A. O'Donnell Extent of pelvic lymphadenectomy and its impact on outcome in patients diagnosed with bladder cancer: analysis of data from the Surveillance, Epidemiology and End Results Program data base J Urol 169 2003 946 950 (Pubitemid 36188131)
9. M. Abdel-Latif, H. Abol-Enein, and M. El-Baz Nodal involvement in bladder cancer cases treated with radical cystectomy: incidence and prognosis J Urol 172 2004 85 89 (Pubitemid 41615044)
10. P. Russo Editorial comment on "Assessment of the minimum number of lymph nodes needed to detect lymph node invasion at radical nephroureterectomy in patients with upper tract urothelial cancer" Urology 74 2009 1075 1076
11. N.B. Dhar, E.A. Klein, A.M. Reuther, G.N. Thalmann, S. Madersbacher, and U.E. Studer Outcome after radical cystectomy with limited or extended pelvic lymph node dissection J Urol 179 2008 873 878
12. H. Komatsu, N. Tanabe, and S. Kubodera The role of lymphadenectomy in the treatment of transitional cell carcinoma of the upper urinary tract J Urol 157 1997 1622 1624 (Pubitemid 27171738)
13. H. Miyake, I. Hara, and K. Gohji The significance of lymphadenectomy in transitional cell carcinoma of the upper urinary tract BJU Int 82 1998 494 498 (Pubitemid 28477288)
14. T. Kondo, H. Nakazawa, F. Ito, and Y. Hashimoto Impact of the extent of regional lymphadenectomy on the survival of patients with urothelial carcinoma of the upper urinary tract J Urol 178 2007 1212 1217 (Pubitemid 47368417)
15. M.A. Brausi, M. Gavioli, and G. De Luca Retroperitoneal lymph node dissection (RPLD) in conjunction with nephroureterectomy in the treatment of infiltrative transitional cell carcinoma (TCC) of the upper urinary tract: impact on survival Eur Urol 52 2007 1414 1420 (Pubitemid 47445989)
16. M. Roscigno, C. Cozzarini, and R. Bertini Prognostic value of lymph node dissection in patients with muscle-invasive transitional cell carcinoma of the upper urinary tract Eur Urol 53 2008 794 802
17. M. Roscigno, S.F. Shariat, and M. Freschi Assessment of the minimum number of lymph nodes needed to detect lymph node invasion at radical nephroureterectomy in patients with upper tract urothelial cancer Urology 74 2009 1070 1074
18. M. Roscigno, S.F. Shariat, and V. Margulis Impact of lymph node dissection on cancer specific survival in patients with upper tract urothelial carcinoma treated with radical nephroureterectomy J Urol 181 2009 2482 2489
19. M. Roscigno, S.F. Shariat, and V. Margulis The extent of lymphadenectomy seems to be associated with better survival in patients with nonmetastatic upper-tract urothelial carcinoma: how many lymph nodes should be removed? Eur Urol 56 2009 512 519
20. M.F. Arancibia, C. Bolenz, M.S. Michel, F.X. Keeley Jr., and P. Alken The modern management of upper tract urothelial cancers: surgical treatment BJU Int 99 2007 978 981 (Pubitemid 46587894)
21. T. Kondo, H. Nakazawa, and F. Ito Primary site and incidence of lymph node metastases in urothelial carcinoma of upper urinary tract Urology 69 2007 265 269 (Pubitemid 46274933)
22. R. Zigeuner, S.F. Shariat, and V. Margulis Tumor necrosis is an indicator of aggressive biology in patients with urothelial carcinoma of the upper urinary tract Eur Urol 57 2010 575 581
23. Wheat JC, Weizer AZ, Wolf Jr JS, et al. Concomitant carcinoma in situ is a feature of aggressive disease in patients with organ confined urothelial carcinoma following radical nephroureterectomy. Urol Oncol. In press. DOI:10.1016/j.urolonc.2010.01.001.
24. G. Novara, V. De Marco, and F. Gottardo Independent predictors of cancer-specific survival in transitional cell carcinoma of the upper urinary tract. Multi-institutional dataset from 3 European centers Cancer 110 2007 1715 1722 (Pubitemid 47557295)
25. V. Margulis, S.F. Shariat, and S.F. Matin Outcomes of radical nephroureterectomy: a series from the Upper Tract Urothelial Carcinoma Collaboration Cancer 115 2009 1224 1233
26. T. Abe, N. Shinohara, and T. Harabayashi The role of lymph-node dissection in the treatment of upper urinary tract cancer BJU Int 102 2008 576 579
27. G.A. Brown, J.E. Busby, and C.G. Wood Nephroureterectomy for treating upper urinary tract transitional cell carcinoma: time to change the treatment paradigm? BJU Int 98 2006 1176 1180 (Pubitemid 44721220)
28. F.P. Secin, T.M. Koppie, and J.I. Salamanca Evaluation of regional lymph node dissection in patients with upper urinary tract urothelial cancer Int J Urol 14 2007 26 32 (Pubitemid 44952578)
29. G. Lughezzani, C. Jeldres, and H. Isbarn A critical appraisal of the value of lymph node dissection at nephroureterectomy for upper urothelial carcinoma Urology 75 2010 118 124
30. V. Margulis, R.F. Youssef, and P.I. Karakiewicz Preoperative multivariable prognostic model for prediction of nonorgan confined urothelial carcinoma of the upper urinary tract J Urol 184 2010 453 458
31. J.C. Brien, S.F. Shariat, and M.P. Herman Preoperative hydronephrosis, ureteroscopic biopsy grade and urinary cytology can improve prediction of advanced upper tract urothelial carcinoma J Urol 184 2010 69 73
32. G. Giannarini, T.M. Kessler, H.C. Thoeny, D.P. Nguyen, C. Meissner, and U.E. Studer Do patients benefit from routine follow-up to detect recurrences after radical cystectomy and ileal orthotopic bladder substitution? Eur Urol 58 2010 486 494
33. B.G. Volkmer, R. Kuefer, G.C. Bartsch Jr., K. Gust, and R.E. Hautmann Oncological followup after radical cystectomy for bladder cancer - is there any benefit? J Urol 181 2009 1587 1593
34. C. Bolenz, S.F. Shariat, and M.I. Fernandez Risk stratification of patients with nodal involvement in upper tract urothelial carcinoma: value of lymph node density BJU Int 103 2008 302 306
35. J.P. Stein, J. Cai, and S. Groshen Risk factors for patients with pelvic lymph node metastases following radical cystectomy with en bloc pelvic lymphadenectomy: the concept of lymph node density J Urol 170 2003 35 41 (Pubitemid 36734405)
36. A.R. Feinstein, D.M. Sosin, and C.K. Wells The Will Rogers phenomenon. Stage migration and new diagnostic techniques as a source of misleading statistics for survival in cancer N Engl J Med 312 1985 1604 1608 (Pubitemid 15062653)
37. T. Kondo, Y. Hashimoto, and H. Kobayashi Template-based lymphadenectomy in urothelial carcinoma of the upper urinary tract: impact on patient survival Int J Urol 17 2010 848 854
38. G. Simone, R. Papalia, and S. Guaglianone Laparoscopic versus open nephroureterectomy: perioperative and oncologic outcomes from a randomised prospective study Eur Urol 56 2009 520 526
39. U. Capitanio, S.F. Shariat, and H. Isbarn Comparison of oncologic outcomes for open and laparoscopic nephroureterectomy: a multi-institutional analysis of 1249 cases Eur Urol 56 2009 1 9
40. R. Abouassaly, S.M.H. Alibhai, N. Timilshina, N. Fleshner, and A. Finelli Troubling outcomes from population-level analysis of surgery for upper tract urothelial carcinoma Urology 76 2010 895 901
41. M. Rouprêt, R. Zigeuner, and J. Palou European guidelines for the diagnosis and management of upper urinary tract urothelial cell carcinomas: 2011 update Eur Urol 59 2011 584 594
42. J.E. Busby, G.A. Brown, and S.F. Matin Comparing lymphadenectomy during radical nephroureterectomy: open versus laparoscopic Urology 71 2008 413 416 (Pubitemid 351374710)
43. Y.S. Song, J.S. Cho, and K.S. Cho Efficacy of adjuvant gemcitabine-cisplatin chemotherapy: a comparative study between locally advanced transitional cell carcinoma of the bladder and upper urinary tract Urol Int 85 2010 47 51
44. N.J. Hellenthal, S.F. Shariat, and V. Margulis Adjuvant chemotherapy for high risk upper tract urothelial carcinoma: results from the upper tract urothelial carcinoma collaboration J Urol 182 2009 900 906
45. O'Donnell PH, Stadler WM. The role of chemotherapy in upper tract urothelial carcinoma. Adv Urol 2009:419028.
46. Youssef RF, Shariat SF, Lotan Y, et al. Upper urinary tract urothelial carcinoma with loco-regional nodal metastases: insights from the upper tract urothelial carcinoma collaboration. BJU Int. In press. DOI:10.1111/j.1464-410X. 2011.10075.x.
47. S.F. Matin, V. Margulis, and A. Kamat Incidence of downstaging and complete remission after neoadjuvant chemotherapy for high-risk upper tract transitional cell carcinoma Cancer 116 2010 3127 3134